Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor-induced immunosuppression].

S Paul1, B Calmels, E Régulier

  • 1Transgène SA, Laboratoire d'immunologie clinique et expérimentale, 2, rue Adolphe-Hirn, 67082 Strasbourg cedex, France.

Annales De Biologie Clinique
|April 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic.

Bone marrow transplantation·2021
Same author

[CAR-T cells: Lymphocytes that express a chimeric antigen receptor].

La Revue de medecine interne·2019
Same author

Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT.

Bone marrow transplantation·2018
Same author

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.

Bone marrow transplantation·2017
Same author

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML.

Bone marrow transplantation·2016
Same author

First Ever Storage of Ultracold Neutrons in a Magnetic Trap Made of Permanent Magnets.

Journal of research of the National Institute of Standards and Technology·2016

Tumor immunology explores how the immune system fights cancer (immune surveillance) and how tumors evade it (immune escape). Understanding these interactions is key for developing effective cancer immunotherapies.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Context:

  • Tumor immunology is founded on immune surveillance and tumor immune escape mechanisms.
  • Defects in T lymphocyte function infiltrating cancers can permit tumor growth.
  • Tumor cells express self-antigens, potentially hindering effective anti-tumor immune responses.

Purpose:

  • To elucidate the fundamental concepts of tumor immunology, including immune surveillance and immune escape.
  • To highlight the role of immune cell defects and tumor-associated antigens in cancer progression.
  • To underscore the importance of understanding cancer-immune cell interactions for therapeutic strategies.

Summary:

  • The immune system's ability to recognize and eliminate tumor cells (immune surveillance) is a critical concept in cancer biology.

Related Experiment Videos

  • Tumors can evade immune detection through various mechanisms, including altering immune cell function and composition within the tumor microenvironment.
  • Biochemical defects in tumor-infiltrating T lymphocytes and the expression of self-antigens on cancer cells contribute to immune evasion.

    • Impact:

    • Understanding tumor immunology provides a basis for developing novel cancer immunotherapies.
    • Identifying mechanisms of immune escape can lead to strategies to enhance anti-tumor immunity.
    • This knowledge is crucial for advancing clinical applications aimed at harnessing the immune system to fight cancer.